Clinical Research

Advancing the Future of Medicine

Our Clinical Research Department seeks to safely advance allergy and asthma medications with controlled clinical trials. The FDA regulates the testing of new medications through various steps. Phase 2 and 3 clinical trials, which we oversee, occur after the medication’s general safety has been demonstrated in order to determine its effectiveness and potential interaction with other medications.

Help Yourself and Others

Clinical Research participants have the benefit of the best new medications, with peripheral health screenings and financial compensation. Our research department has been directly involved with the clinical trials leading to FDA approval of such medications as Azmacort, Advair, Singulair, Allegra, Flonase and Xolair.

Who Qualifies?

Trials typically include patients between 18 and 65, who are reasonably healthy and neither pregnant nor planning to become so. For asthma trials, we’re looking for those with mild-to-moderate asthma. Allergy trial participants are generally required to have had allergy symptoms for two prior seasons and skin prick testing within the prior 12 months.

For Information on Participating

Contact Laurie or Tom in our Research Department, (480) 675-8982. Additional information available at

Contact Us Today arrow